Malignant otitis externa: An updated review

José Luis Treviño González1, Laura Lisset Reyes Suárez1, Jesús Eduardo Hernández de León1

  • 1Department of Otolaryngology and Head and Neck Surgery, University of Nuevo Leon, Mexico.

Insights

Malignant otitis externa, a severe Pseudomonas aeruginosa infection, primarily affects diabetics and the elderly. Prompt diagnosis and individualized treatment, including antibiotics and diabetes control, are crucial for patient outcomes.

Area of Science:

  • Infectious Diseases
  • Otolaryngology
  • Radiology

Background:

  • Malignant otitis externa (MOE) is a severe necrotizing infection of the external auditory canal and skull base.
  • Pseudomonas aeruginosa is the predominant pathogen, frequently affecting diabetic, elderly, and immunocompromised individuals.
  • Key clinical signs include persistent otalgia, chronic otorrhea, and potential facial nerve palsy.

Purpose of the Study:

  • To provide an updated review of malignant otitis externa.
  • To cover epidemiology, clinical manifestations, diagnosis, and treatment strategies.
  • To offer insights for clinical practice and future research.

Main Methods:

  • Review of recent scientific literature on malignant otitis externa.
  • Analysis of diagnostic modalities including computed tomography (CT) and Technetium-99m scans.
  • Evaluation of current treatment protocols and management strategies.

Main Results:

  • MOE is a progressive infection with characteristic clinical presentations.
  • Diagnostic imaging like CT and Technetium-99m scintigraphy are vital.
  • Treatment necessitates a multidisciplinary approach with systemic antibiotics and strict diabetes management.

Conclusions:

  • Individualized treatment plans are essential for managing malignant otitis externa.
  • Long-term patient follow-up (at least one year) is critical post-treatment.
  • Surgical intervention may be required for refractory cases or facial nerve involvement.